Your browser doesn't support javascript.
loading
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.
Ben Aim, Laurene; Maher, Eamonn R; Cascon, Alberto; Barlier, Anne; Giraud, Sophie; Ercolino, Tonino; Pigny, Pascal; Clifton-Bligh, Roderick J; Mirebeau-Prunier, Delphine; Mohamed, Amira; Favier, Judith; Gimenez-Roqueplo, Anne-Paule; Schiavi, Francesca; Toledo, Rodrigo A; Dahia, Patricia L; Robledo, Mercedes; Bayley, Jean Pierre; Burnichon, Nelly.
Afiliación
  • Ben Aim L; Genetics Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France.
  • Maher ER; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Cascon A; Hereditary Endocrine Cancer Group, CNIO, Madrid, Spain.
  • Barlier A; Laboratory of Molecular Biology, La Conception Hospital, Marseille, France.
  • Giraud S; Department of Genetics, Hospices Civils de Lyon, Bron, France.
  • Ercolino T; Endocrinology Unit, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  • Pigny P; Institut de Biochimie & Biologie Moléculaire, Lille University Hospital Center, Lille, France.
  • Clifton-Bligh RJ; Department of Endocrinology, Royal North Shore Hospital, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia.
  • Mirebeau-Prunier D; Département de Biochimie et Génétique, CHU Angers, Angers, France.
  • Mohamed A; Laboratory of Molecular Biology, La Conception Hospital, Marseille, France.
  • Favier J; Université de Paris, PARCC, INSERM, Equipe Labellisée par la Ligue contre le Cancer, Paris, France.
  • Gimenez-Roqueplo AP; Genetics Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France.
  • Schiavi F; Université de Paris, PARCC, INSERM, Equipe Labellisée par la Ligue contre le Cancer, Paris, France.
  • Toledo RA; Familial Cancer Clinic and Oncoendocrinology, IOV IRCCS, Padova, Italy.
  • Dahia PL; CIBERONC, Gastrointestinal and Endocrine Tumors, VHIO, Barcelona, Spain.
  • Robledo M; Department of Medicine, Division of Hematology and Medical Oncology, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Bayley JP; Hereditary Endocrine Cancer Group, CNIO, Madrid, Spain.
  • Burnichon N; Human Genetics, LUMC, Leiden, The Netherlands.
J Med Genet ; 59(8): 785-792, 2022 08.
Article en En | MEDLINE | ID: mdl-34452955
ABSTRACT

BACKGROUND:

SDHB is one of the major genes predisposing to paraganglioma/pheochromocytoma (PPGL). Identifying pathogenic SDHB variants in patients with PPGL is essential to the management of patients and relatives due to the increased risk of recurrences, metastases and the emergence of non-PPGL tumours. In this context, the 'NGS and PPGL (NGSnPPGL) Study Group' initiated an international effort to collect, annotate and classify SDHB variants and to provide an accurate, expert-curated and freely available SDHB variant database.

METHODS:

A total of 223 distinct SDHB variants from 737 patients were collected worldwide. Using multiple criteria, each variant was first classified according to a 5-tier grouping based on American College of Medical Genetics and NGSnPPGL standardised recommendations and was then manually reviewed by a panel of experts in the field.

RESULTS:

This multistep process resulted in 23 benign/likely benign, 149 pathogenic/likely pathogenic variants and 51 variants of unknown significance (VUS). Expert curation reduced by half the number of variants initially classified as VUS. Variant classifications are publicly accessible via the Leiden Open Variation Database system (https//databases.lovd.nl/shared/genes/SDHB).

CONCLUSION:

This international initiative by a panel of experts allowed us to establish a consensus classification for 223 SDHB variants that should be used as a routine tool by geneticists in charge of PPGL laboratory diagnosis. This accurate classification of SDHB genetic variants will help to clarify the diagnosis of hereditary PPGL and to improve the clinical care of patients and relatives with PPGL.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article